First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019
The good news: 75% of never-before-inspected firms complied with US drug GMP requirements. The bad news: 25% did not.

The good news: 75% of never-before-inspected firms complied with US drug GMP requirements. The bad news: 25% did not.